Abstract:Nitric oxide (NO) is a ubiquitous, endogenously produced, water-soluble signaling molecule playing critical roles in physiological processes. Nitric oxide plays pleiotropic roles in cancer and, depending on its local concentration, may lead to either tumor progression or tumor suppression. Addition of NO group to a cysteine residue within a protein, termed as S-nitrosylation, plays diverse regulatory roles and affects processes such as metabolism, apoptosis, protein phosphorylation, and regulation of transcription factors. The process of S-nitrosylation has been associated with development of different cancers, including breast cancer. The present review discusses different mechanisms through which NO acts, with special emphasis on breast cancers, and provides detailed insights into reactive nitrogen species, posttranslational modifications of proteins mediated by NO, dual nature of NO in cancers, and the implications of S-nitrosylation in cancers. Our review will generate interest in exploring molecular regulation by NO in different cancers and will have significant therapeutic implications in the management and treatment of breast cancer.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to explore the mechanism of action of nitric oxide (NO) and its -mediated S - nitrosylation in breast cancer. Specifically, the paper discusses how NO affects the development of breast cancer through different mechanisms, including the post - translational modification effects of NO on proteins, such as S - nitrosylation, S - glutathionylation and tyrosine nitration, and how these modifications affect cell signaling pathways, thereby promoting or inhibiting tumor growth and metastasis. In addition, the paper also explores the influence of NO on the tumor microenvironment at different concentrations and its dual role in tumor progression and regression. The paper aims to provide in - depth insights into the molecular regulatory mechanism of NO in breast cancer and important therapeutic implications for the management and treatment of breast cancer. The key points mentioned in the paper include: - **Generation and action of NO**: NO is a highly diffusible and reactive free radical, which is generated by nitric oxide synthase (NOS) catalyzing L - arginine in the presence of oxygen. NO plays an important role in physiological processes, such as neurotransmission, vasodilation and macrophage - mediated immune responses. NO can also act as a messenger molecule and play a role in promoting and inhibiting cancer. - **Role of NOS enzymes**: There are three isoenzymes of NOS enzymes, namely neuronal NOS (nNOS), inducible NOS (iNOS) and endothelial NOS (eNOS), which are encoded in mammalian cells and participate in the generation of NO. The expression and activity of these enzymes are regulated by multiple factors, including calcium ion levels, protein kinase - mediated phosphorylation, transcription factors, etc. - **NO - mediated post - translational modification of proteins**: NO affects the function of proteins through post - translational modifications such as S - nitrosylation, S - glutathionylation and tyrosine nitration. These modifications can change the structure and function of proteins, affect cell signaling pathways, and thus play a key role in the occurrence and development of cancer. - **Role of NO in breast cancer**: The paper discusses in detail the role of NO and its - mediated S - nitrosylation in breast cancer, including its effects on cell proliferation, migration, invasion and chemoresistance. The dual role of NO at different concentrations has also been noted, with low concentrations of NO possibly promoting tumor growth and high concentrations of NO possibly leading to apoptosis. - **Treatment strategies**: Based on the understanding of the mechanism of action of NO in breast cancer, the paper also proposes several potential treatment strategies, such as increasing the bioavailability of NO by supplementing L - arginine or citrulline, using NO - donor drugs, and targeting NOS enzyme modulators, etc. In summary, through an in - depth exploration of the mechanism of action of NO and its - mediated S - nitrosylation in breast cancer, this paper provides a new perspective and potential treatment strategies for the treatment of breast cancer.

Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer